Simulations Plus Inc (SLP)

12.15
0.25 2.00
NASDAQ : Technology
Prev Close 12.40
Open 12.45
Day Low/High 12.05 / 12.51
52 Wk Low/High 6.08 / 11.89
Volume 6.59K
Avg Volume 62.90K
Exchange NASDAQ
Shares Outstanding 17.24M
Market Cap 212.92M
EPS 0.30
P/E Ratio 39.84
Div & Yield 0.20 (1.60%)

Latest News

Simulations Plus To Present At The 7th Annual LD Micro Invitational

Simulations Plus, Inc. (Nasdaq: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, announced that it will be presenting at the 7 th Annual LD...

Simulations Plus To Present At The Needham Emerging Technology Conference

Simulations Plus, Inc. (Nasdaq: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development from the earliest discovery through all phases of clinical...

Simulations Plus About To Put More Money In Your Pocket (SLP)

Looking at the universe of stocks we cover at Dividend Channel, on 5/4/17, Simulations Plus Inc. will trade ex-dividend, for its quarterly dividend of $0.05, payable on 5/15/17.

Simulations Plus To Acquire DILIsym Services, Inc.

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that it has entered into a Stock Purchase Agreement (the...

Dr. Daniel Weiner Joins Simulations Plus Board Of Directors

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that Dr.

Simulations Plus Announces Quarterly Cash Dividend Of $0.05 Per Share

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and consulting services for the pharmaceutical, biotechnology, and chemicals industries, today announced that its board of...

Simulations Plus Establishes Distribution Channel In India With Electrolab

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of modeling and simulation software and consulting services for the pharmaceutical, biotechnology, and chemicals industries, today announced that it has signed a...

Simulations Plus Reports Second Quarter FY2017 Financial Results

Simulations Plus, Inc. (Nasdaq: SLP), the premier provider of simulation and modeling software and consulting services for all phases of pharmaceutical discovery and development from the earliest discovery through all...

Simulations Plus Finalizes Distributor Agreement With Korean Company

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling & simulation solutions for the pharmaceutical, biotechnology, and chemicals industries, today announced that it has entered into a distributor...

Simulations Plus Releases GastroPlus™ Version 9.5

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling & simulation solutions for the pharmaceutical, biotechnology, and chemicals industries, today announced that it has released version 9.

Simulations Plus Sets Date For 2nd Quarter 2017 Earnings Release And Conference Call

Simulations Plus, Inc. (Nasdaq: SLP) announced today that it expects to file its quarterly report on Form 10-Q for the second quarter of its 2017 fiscal year on Monday, April 10, 2017.

Simulations Plus Reports Record Preliminary Revenues For Second Quarter FY2017

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for the second quarter of its fiscal year 2017,...

SLP Ex-Dividend Reminder - 1/26/17

SLP Ex-Dividend Reminder - 1/26/17

Looking at the universe of stocks we cover at Dividend Channel, on 1/26/17, Simulations Plus Inc. will trade ex-dividend, for its quarterly dividend of $0.05, payable on 2/6/17.

Simulations Plus Announces Quarterly Cash Dividend Of $0.05 Per Share

Simulations Plus Announces Quarterly Cash Dividend Of $0.05 Per Share

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that its board of directors has declared its next ongoing quarterly...

Simulations Plus Releases ADMET Predictor™ Version 8.1

Simulations Plus Releases ADMET Predictor™ Version 8.1

Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that it has released Version 8.

Simulations Plus Reports First Quarter FY2017 Financial Results

Simulations Plus Reports First Quarter FY2017 Financial Results

Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for all stages of pharmaceutical discovery and development from the earliest discovery through all...

Simulations Plus Sets Date For 1st Quarter 2017 Earnings Release And Conference Call

Simulations Plus Sets Date For 1st Quarter 2017 Earnings Release And Conference Call

Simulations Plus, Inc. (Nasdaq: SLP) announced today that it expects to file its quarterly report on Form 10-Q for the first quarter of its 2017 fiscal year on Monday, January 9, 2017.

Simulations Plus Reports Record Preliminary Revenues For First Quarter FY2017

Simulations Plus Reports Record Preliminary Revenues For First Quarter FY2017

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for the first quarter of its fiscal year 2017,...

Simulations Plus Reports FY2016 And Fourth Quarter FY2016 Financial Results

Simulations Plus Reports FY2016 And Fourth Quarter FY2016 Financial Results

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, today reported its financial results for its 2016 fiscal year (FY16) and fourth quarter (4Q16) ended August...

Simulations Plus Sets Date For 4th Quarter And Fiscal Year 2016 Earnings Release And Conference Call

Simulations Plus Sets Date For 4th Quarter And Fiscal Year 2016 Earnings Release And Conference Call

Simulations Plus, Inc. (Nasdaq: SLP) announced today that it expects to file Form 10-K for the 2016 fiscal year ended August 31, 2016, with the U.

Reminder - Simulations Plus (SLP) Goes Ex-Dividend Soon

Reminder - Simulations Plus (SLP) Goes Ex-Dividend Soon

Looking at the universe of stocks we cover at Dividend Channel, on 11/8/16, Simulations Plus Inc. will trade ex-dividend, for its quarterly dividend of $0.05, payable on 11/17/16.

Simulations Plus Announces Quarterly Cash Dividend Of $0.05 Per Share

Simulations Plus Announces Quarterly Cash Dividend Of $0.05 Per Share

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that its board of directors has declared its next ongoing quarterly...

Simulations Plus Joins European SimInhale Consortium

Simulations Plus Joins European SimInhale Consortium

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of modeling and simulation software for pharmaceutical discovery and development, today announced that it has been accepted into the SimInhale COST (European...

Simulations Plus Reports Preliminary Revenues For Fourth Quarter And Fiscal Year 2016

Simulations Plus Reports Preliminary Revenues For Fourth Quarter And Fiscal Year 2016

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for its fiscal fourth quarter (4QFY16) and full...

Simulations Plus Releases PKPlus™ Version 1.0

Simulations Plus Releases PKPlus™ Version 1.0

Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that it has released version 1.

Simulations Plus Releases ADMET Predictor™ Version 8.0

Simulations Plus Releases ADMET Predictor™ Version 8.0

Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that it has released Version 8.

Simulations Plus Announces Quarterly Cash Dividend Of $0.05 Per Share

Simulations Plus Announces Quarterly Cash Dividend Of $0.05 Per Share

Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that its board of directors has declared its next ongoing quarterly...

Simulations Plus Reports Third Quarter FY2016 Financial Results

Simulations Plus Reports Third Quarter FY2016 Financial Results

Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development from the earliest discovery through all phases of clinical...